Inventor · disambiguated record

Gregory H. Bird

Also filed as: BIRD GREGORY · BIRD GREGORY H

26 granted patents·14 pending applications·86 citations·filing 2008–2025

95Inventor score

Technology areasC07K A61P A61K C12N G01N

Files withDANA FARBER CANCER INST INC28 WALENSKY LOREN D5 HARVARD COLLEGE4 DANIAL NIKA N1 MASSACHUSETTS INST TECHNOLOGY1

Top patents by PatentIndex Score

40 records

0189US11105810B2Reagents for quantitative mass spectrometryHARVARD COLLEGE·Filed 2019·Granted Aug 31, 2021·2 cites·7 claims
0288US11982674B2Reagents for quantitative mass spectrometryHARVARD COLLEGE·Filed 2021·Granted May 14, 2024·1 cites·10 claims
0388US11078246B2Peptides binding to Bfl-1DANA FARBER CANCER INST INC·Filed 2016·Granted Aug 3, 2021·4 cites·76 claims
0488US10464975B2Stabilized anti-microbial peptidesDANA FARBER CANCER INST INC·Filed 2016·Granted Nov 5, 2019·8 cites·79 claims
0588US9296805B2Stabilized insulinotropic peptides and methods of useWALENSKY LOREN D·Filed 2011·Granted Mar 29, 2016·11 cites·21 claims
0687US12153051B2Reagents for quantitative mass spectrometryHARVARD COLLEGE·Filed 2024·Granted Nov 26, 2024·0 cites·20 claims
0787US9695224B2Stabilized insulinotropic peptides and methods of useDANA FARBER CANCER INST INC·Filed 2016·Granted Jul 4, 2017·6 cites·5 claims
0885US11834520B2Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptidesDANA FARBER CANCER INST INC·Filed 2018·Granted Dec 5, 2023·3 cites·26 claims
0985US10703785B2Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9WALENSKY LOREN D·Filed 2012·Granted Jul 7, 2020·5 cites·20 claims
1085US10259848B2Compositions and methods comprising hydrocarbon-stapled polypeptidesDANA FARBER CANCER INST INC·Filed 2016·Granted Apr 16, 2019·4 cites·15 claims
1184US9822165B2Hydrocarbon stapled stabilized alpha-helices of the HIV-1 GP41 membrane proximal external regionWALENSKY LOREN D·Filed 2010·Granted Nov 21, 2017·8 cites·18 claims
1284US8921323B2Methods and compositions for modulating BCL-2 family polypeptidesWALENSKY LOREN D·Filed 2008·Granted Dec 30, 2014·10 cites·2 claims
1382US11466064B2Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing lossDANA FARBER CANCER INST INC·Filed 2017·Granted Oct 11, 2022·2 cites·14 claims
1482US11220532B2Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9DANA FARBER CANCER INST INC·Filed 2020·Granted Jan 11, 2022·1 cites·17 claims
1582US10487129B2Stabilized insulinotropic peptides and methods of useDANA FARBER CANCER INST INC·Filed 2017·Granted Nov 26, 2019·3 cites·14 claims
1682US10308926B2Stablized EZH2 peptidesDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 4, 2019·3 cites·43 claims
1782US9290545B2Compositions and methods for the treatment of viral infectionsWALENSKY LOREN D·Filed 2010·Granted Mar 22, 2016·5 cites·11 claims
1881US10273290B2Hydrocarbon double-stapled stabilized HIV-1 GP41 heptad repeat domain peptidesDANA FARBER CANCER INST INC·Filed 2017·Granted Apr 30, 2019·3 cites·18 claims
1976US10077290B2Stabilized antiviral fusion helicesDANA FARBER CANCER INST INC·Filed 2012·Granted Sep 18, 2018·3 cites·37 claims
2075US11169155B2Reagents for quantitative mass spectrometryHARVARD COLLEGE·Filed 2016·Granted Nov 9, 2021·1 cites·8 claims
2175US10716828B2Methods of modulating cellular homeostatic pathways and cellular survivalDANIAL NIKA N·Filed 2008·Granted Jul 21, 2020·3 cites·14 claims
2273US12441775B2BCL-W polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing lossDANA FARBER CANCER INST INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
2372US12466853B2Selective targeting of apoptosis proteins by structurally-stabilized and/or cysteine-reactive NOXA peptidesDANA FARBER CANCER INST INC·Filed 2023·Granted Nov 11, 2025·0 cites·28 claims
2469US2022213146A1Stabilized peptides for covalent binding to target proteinDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
2568US2025288658A1Ebolavirus surface glycoprotein peptides, conjugates, and uses thereofDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
2666US2024140999A1Stabilized peptide-mediated targeted protein degradationDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
2764US2025084128A1ANTIVIRAL STRUCTURALLY-STAPLED SARS-CoV-2 PEPTIDE-CHOLESTEROL CONJUGATES AND USES THEREOFDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
2864US2025368694A1Selective targeting of ubiquitin- and ubiquitin-like e1-activating enzymes by structurally-stabilized peptidesDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
2962US2025163115A1BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing LossDANA FARBER CANCER INST INC·Filed 2025·Application pending·0 cites
3059US12358960B2Selective targeting of ubiquitin- and ubiquitin-like E1-activating enzymes by structurally-stabilized peptidesDANA FARBER CANCER INST INC·Filed 2020·Granted Jul 15, 2025·0 cites·28 claims
3157US2020231638A1Stabilized anti-microbial peptidesDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
3256US12344643B2Compositions and methods for inhibition of FOXP3UNIV CHICAGO·Filed 2017·Granted Jul 1, 2025·0 cites·13 claims
3355US2024124529A1ANTIVIRAL STRUCTURALLY-STABILIZED SARS-CoV-2 PEPTIDES AND USES THEREOFDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
3455US2019002506A1Stabilized peptides for covalent binding to target proteinDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
3554US2023183309A1Structurally-stabilized glucagon-like peptide 1 peptides and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
3653US2024002450A1Antiviral structurally-stabilized ebolavirus peptides and uses thereofDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
3750US2020354413A1Stabilized peptide-mediated targeted protein degradationDANA FARBER CANCER INST INC·Filed 2018·Application pending·0 cites
3849US2016152667A1Compositions and methods for the treatment of viral infectionsDANA FARBER CANCER INST INC·Filed 2016·Application pending·0 cites
3941US2019048038A1Method for generating cell-penetrating stapled peptides that lack nonspecific membrane-lytic properties for therapeutic targetingDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
4032US11142554B2Selective Mcl-1 binding peptidesMASSACHUSETTS INST TECHNOLOGY·Filed 2016·Granted Oct 12, 2021·0 cites·16 claims

Join the waitlist — get patent alerts

Get an alert when Gregory H. Bird files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →